Some physical factors affecting the enhanced blepharoptotic activity of orally administered reserpine-cholanic acid coprecipitates.
D000818:Animals; D001647:Bile Acids and Salts / Q000008:administration & dosage; D001763:Blepharoptosis / Q000139:chemically induced; D004357:Drug Synergism; D006863:Hydrogen-Ion Concentration; D051379:Mice; D012110:Reserpine / Q000008:administration & dosage; D012995:Solubility; D013500:Surface Tension
D001647:Bile Acids and Salts; D012110:Reserpine